Genotyping of Cryptosporidium parvum isolates obtained from humans in South Africa

• Autorzy: Paulsen L , Venter S N
• Języki publikacji: EN

Abstrakty

EN

Cryptosporidium parvum is endemic to South Africa. In order to provide direction for prevention strategies, information on the dominant genotype involved in human infections is required. A combination of diethyl ether extraction, sodium chloride flotation and immuno-magnetic separation (IMS) was used for maximum recovery of oocysts from faecal samples. In order to improve the sensitivity of PCR-RFLP analysis of the Cryptosporidium oocyst wall protein (COWP) gene, a nested PCR was developed. RFLP analysis was done on a 553 bp segment obtained from the final nested PCR reaction to distinguish between C. parvum genotype 1 (human exclusive type) and genotype 2 (broad host range). Overall, genotype 2 was detected in 10 samples, whereas genotype 1 was detected in the remaining 40 samples. The high incidence of genotype 1 parasites (80%) implies hat direct and indirect human transmission plays a dominant role in the epidemiology of the disease caused by this parasite in the study area.

Słowa kluczowe

EN

flotation; infection risk; sodium chloride; South Africa; epidemiology; host; oocyst; Cryptosporidium parvum; parasite; wall protein; man; genotype; fecal sample; polymerase chain reaction; immuno-magnetic separation

• Wydawca: -
• Czasopismo: Acta Parasitologica
• Rocznik: 2003
• Tom: 48
• Numer: 2
• Opis fizyczny: p.135-137

Twórcy

autor

Paulsen L

• Department of Microbiology and Plant Pathology, University of Pretoria, Pretoria, 0002, South Africa

autor

Venter S N

• Department of Microbiology and Plant Pathology, University of Pretoria, Pretoria, 0002, South Africa

Bibliografia

• Awad-El-Kariem F.M., Robinson H.A., Dyson D.A., Evans D., Wright S., Fox M.T., McDonald V. 1995. Differentiation between human and animal strains of Cryptosporidium parvum using isoenzyme typing. Parasitology, 110, 129-132.
• Awad-El-Kariem F.M., Robinson H.A., McDonald V., Evans D., Dyson D.A. 1993. Is human cryptosporidiosis a zoonotic disease? Lancet, 341, 1535.
• Awad-El-Kariem F.M., Robinson H.A., Petry F., McDonald V., Evans D., Casemore D. 1998. Differentiating between human and animal isolates of Cryptosporidium parvum using molecular and biological markers. Parasitology Research, 84, 297-301.
• Casemore D.P. 1989. Cryptosporidiosis: another source. British Medical Journal, 298, 750-751.
• Deng M.Q.I., Cliver D.O. 1997. Differentiation of Cryptosporidium parvum isolates by a simplified randomly amplified polymorphic DNA technique. Applied and Environmental Microbiology, 64, 1954-1957.
• Elwin K., Chalmers R.M., Roberts R., Guy E.C., Casemore D.P. 2001. Modification of a rapid method for the identification of gene- specific polymorphisms in Cryptosporidium parvum and its application to clinical and epidemiological investigations. Applied and Environmental Microbiology, 67, 5581-5584.
• Fayer R. 1997. Cryptosporidium and cryptosporidiosis, CRC Press, Boca Raton.
• Guyot K., Follet-Dumoulin A., Lelievre E., Sarfati C., Rabodonirina M., Nevez G., Cailliez J.C., Camus D., Dei-Cas E. 2001. Molecular characterization of Cryptosporidium isolates obtained from humans in France. Journal of Clinical Microbiology, 39, 3472-3480.
• Leav B.A., Mackay M.R., Anyanwu A., O’Connor R.M., Cevallos A.M., Kindra G., Rollins N.C., Bennish M.L., Nelson R.G., Ward H.D. 2002. Analysis of sequence diversity at the highly polymorphic Cpgp40/15 locus among Cryptosporidium isolates from human immunodeficiency virus-infected children in South Africa. Infection and Immunity, 70,3881-3890.
• McDonald V., Stables R., Warhurst D.C., Barer M.R., Blewett D.A., Chapman H.D., Connolly, G.M., Chiodini P.L., McAdam K.P. 1990. In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs. Antimicrobial Agents and Chemotherapy, 34, 1498-1500.
• McLauchlin J., Amar C., Pedraza-Diaz S., Nichols L. 2000. Molecular epidemiological analysis of Cryptosporidium spp. in the United Kingdom: results of genotyping Cryptosporidium spp. in 1,705 fecal samples from humans and 105 fecal samples from livestock animals. Journal of Clinical Microbiology, 38, 3984-3990.
• Miron D., Kenes J., Dagan R. 1991. Calves as a source of an outbreak of cryptosporidiosis among young children in an agricultural closed community. Pediatric Infectious Disease Journal, 10, 438-441.
• Pedraza-Diaz S., Amar C., McLauchlin J. 2000. The identification and characterisation of an unusual genotype of Cryptosporidium from human faeces as Cryptosporidium meleagridis. FEMS Microbiology Letters, 189, 189-194.
• Pozio E., Gomez Morales M.A., Barbieri F.M., La Rosa G. 1992. Ciyptosporidium: Different behaviour in calves of isolates of human origin. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 636-638.
• Spano F., Putignani L., McLauchlin J., Casemore P., Crisanti A. 1997. PCR-RPLP analysis of the Cryptosporidium oocyst wall protein (COPW) gene discriminates between C. wrairi and C. parvum, and between C. parvum isolates of human and animal origin. FEMS Microbiology Letters, 150, 209-217.
• Sulaiman I.M., Xiao L., Yang C., Escalante L., Moore A., Beard C.B., Arrowood M.J., Lai A.A. 1998. Differentiating human from animal isolates of Cryptosporidium parvum. Emerging Infectious Disease, 4, 681-685.
• Tzipori S., Griffiths J.K. 1998. Natural history and biology of Cryptosporidium parvum. Advances in Parasitology, 40, 5-36.
• UNAIDS. 2002. Epidemiological fact sheets on HIV/AIDS and sexually transmitted infections: South Africa. World Health Organisation, Geneva.
• Xiao L., Morgan U.M., Limor J., Escalante A., Arrowood M., Shulaw W., Thompson R.C.A., Fayer R., Lal A.A. 1999. Genetic diversity within Cryptosporidium parvum and related Cryptosporidium species. Applied and Environmental Microbiology, 65, 3386-3391.